SCHEMBL7604677

SCHEMBL7604677

CC(C)COCn1c(=O)c2c(ncn2Cc2ccccc2)n(C)c1=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.67
HIF1A Q16665 1/20 0.67
PDE1A P54750 4/20 0.65
PDE1B Q01064 4/20 0.65
PDE1C Q14123 4/20 0.65
SMN1; SMN2 Q16637 5/20 0.64
RXFP1 Q9HBX9 2/20 0.64
ADORA2B P29275 1/20 0.64
HTT P42858 2/20 0.52
UBE2N P61088 2/20 0.52
GLA P06280 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
LMNA P02545 2/20 0.51
ALDH1A1 P00352 2/20 0.51
MAPK1 P28482 1/20 0.51
PDE2A O00408 3/20 0.51
TP53 P04637 1/20 0.50
CASP1 P29466 1/20 0.49
TSHR P16473 1/20 0.49
ABCC8 Q09428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7465110 0.88 POLB (0.71) POLBHIF1APDE1APDE1BPDE1C
SCHEMBL7603292 0.85 POLB (0.74) POLBHIF1APDE1APDE1BPDE1C
SCHEMBL7603804 0.85 POLB (0.67) POLBHIF1APDE1APDE1BPDE1C
SCHEMBL11014928 0.84 POLB (0.83) POLBHIF1APDE1APDE1BPDE1C
SCHEMBL7608447 0.81 POLB (0.67) POLBHIF1APDE1APDE1BPDE1C
SCHEMBL20011033 0.79 SMN1; SMN2 (0.76) POLBHIF1APDE1APDE1BPDE1C
SCHEMBL5718879 0.79 POLB (0.65) POLBHIF1APDE1APDE1BPDE1C
SCHEMBL7608305 0.79 POLB (0.75) POLBHIF1APDE1APDE1BPDE1C
SCHEMBL7459561 0.79 POLB (0.65) POLBHIF1APDE1APDE1BPDE1C
SCHEMBL1944405 0.79 ADORA2B (1.00) POLBHIF1APDE1APDE1BPDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 EP disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 US disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 EP disclosed